Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.
Financial Results:
Alkem Laboratories Ltd reported Revenues for Q4FY24 of ₹2,936.00 Crores up from ₹2,903.00 Crore year on year, a rise of 1.14%.
Total Expenses for Q4FY24 of ₹2,644.00 Crores down from ₹2,656.00 Crores year on year, a fall of 0.45%.
Consolidated Net Profit of ₹304.00 Crores up 347.06% from ₹68.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹24.55, up 313.30% from ₹5.94 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.